• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 1157
  • 852
  • 570
  • 570
  • 570
  • 570
  • 570
  • 568
  • 169
  • 55
  • 43
  • 3
  • 2
  • 2
  • 1
  • Tagged with
  • 2953
  • 2953
  • 1843
  • 1719
  • 1264
  • 1196
  • 1194
  • 1181
  • 1181
  • 1181
  • 1181
  • 1181
  • 357
  • 329
  • 329
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
391

Cardiopulmonary resuscitation: Improving the weakest link in the chain of survival for out-of-hospital cardiac arrest

Vaillancourt, Christian January 2003 (has links)
Background. Bystander CPR is associated with improved survival from cardiac arrest, the first cause of mortality in Canada. Objectives. To improve bystander CPR rates and survival from out-of-hospital cardiac arrest. Methods. A retrospective and prospective analysis of data on cardiac arrest, a systematic review of bystander CPR, a trial designed for improving survival from out-of-hospital cardiac arrest. Results. 7707 out-of-hospital cardiac arrests (1995--2000) with bystander CPR rate (16.5%) and overall survival to discharge (4%). Cardiac arrests are in residential locations (84.7%). Increasing bystander CPR rates could significantly improve survival in residential dwellings (OR 3.6; 95%CI 2.9--4.6). We systematically reviewed 221 publications to plan the intervention for our suggested cluster randomized trial. The study is feasible over a 3 to 5-year period. Conclusions. Public health intervention in the field of bystander CPR will improve survival from cardiac arrest. Our study could significantly affect other international communities equipped with an existing EMS.
392

XIAP-mediated rescue of ischemic neural rat retina from death

Renwick, Joanna January 2004 (has links)
XIAP-mediated gene therapy has been shown to protect brain neurons from ischemic cell death. However, it has not been shown whether XIAP can protect retinal neurons as well. To determine this, an acute retinal ischemia rat model was utilized. Eyes were injected with AAV-XIAP or AAV-GFP and, six weeks later, rendered ischemic by raising intraocular pressure to 110 mmHg and maintaining the pressure for one hour. Retinas were analyzed both functionally and structurally at various time points following ischemia. Functional analysis shows that XIAP, when overexpressed, rescues retinal neurons up to 4 weeks post-ischemia (wpi). Structural rescue is also evident from cell counts of H+E stained retinas. There are also significantly less TUNEL positive cells in the inner nuclear layer of the XIAP-treated retinas at 24 hpi. Therefore, XIAP-mediated gene therapy appears to functionally and structurally rescue retinal neurons from death following a transient ischemic episode.
393

Cost effectiveness analysis of abacavirlamivudine versus tenofoviremtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients

Giguere, Pierre January 2010 (has links)
Introduction: Current recommendations for the treatment of HIV include the use of dual nucleoside reverse transcriptase inhibitors, namely abacavir/lamivudine or tenofovir/emtricitabine. This study is to compare the cost-effectiveness of these two alternatives in the treatment of HIV treatment-naive patients. Methods: A review of the literature was performed to identify relevant randomized controlled trials and economic models. The economic model described by Richter using maximal virologic response and rate of failure as efficacy parameters was adapted to take into consideration the effect of HLA-B*5701 genotyping. Indirect comparison technique was used to ascertain the estimate of efficacy parameters. Sensitivity analyses were performed on costs, efficacy parameters and utilities. Results: Abacavir/lamivudine was dominant over tenofovir/emtricitabine. Efficacy parameters, but not costs and utilities, was very sensitive with a small variation leading to tenofovir/emtricitabine dominance. Conclusion: Abacavir/lamivudine is dominant over tenofovir/emtricitabine in treatment-naive HIV-infected patients. Results are extremely sensitive to efficacy parameters.
394

Uncontrolled blood pressure among hypertensive older adult patients in family practice settings: The contribution of physician and patient characteristics

Ichim, Daniela January 2010 (has links)
Objective: To determine the patient and physician characteristics associated with blood pressure control among older hypertensive patients in family practice, the prevalence of hypertension and the percent of hypertensive patients with controlled blood pressure. Methods: A systematic review has been performed of published studies which reported an analysis of the association between patient and physician characteristics and hypertension control; Data collected in a retrospective review of patients' health records in 28 family practices and a questionnaire for the participating family physicians has been analyzed. Hierarchical logistic modeling has been conducted to determine the predictors for blood pressure control. Results: More than half of the patients were hypertensive. Among hypertensive patients, almost half had their blood pressure under control. The predictors for good blood pressure control were male gender, presence of cardiovascular disease or nephropathy, less than five blood pressure readings/year and young age of the physician. Diabetes predicted poor blood pressure control. Conclusion: Although blood pressure control has improved considerably, more than half of hypertensive patients remain poorly controlled. Selected patient characteristics and physician practice behavior and characteristics were predictors of the blood pressure control.
395

Evaluating the efficacy and safety of unfractionated heparin in patients diagnosed with sepsis

Zarychanski, Ryan January 2010 (has links)
Statement of the Problem: Unfractionated heparin (UFH) is an anticoagulant with anti-inflammatory properties. The efficacy and safety of UFH in severe sepsis or septic shock has yet to be evaluated in clinical trials. Methods of Investigation: We performed a systematic review to evaluate the current evidence regarding the use of heparin in patients with sepsis. We then conducted a cross-sectional survey to evaluate the perceived utility and current use of anticoagulants in sepsis, to assess the degree of certainty regarding clinical benefits and harms of heparin, and to assess the willingness of physicians to consider future clinical trials of heparin. Results: The pooled OR for mortality in 7 trials comparing heparin to any other intervention was 0.88 (95%CI 0.74 to 1.05, I2 0%, n=2473). A large observational cohort study also showed a similar reduction in death associated with heparin (HR 0.85, 95%CI 0.73 to 1.00, n=1390). Data from the national survey indicate that 89% (n=279) of critical care physicians believe that anticoagulant therapies used to modulate host inflammation in patients with severe sepsis or septic shock are clinically important, but not routinely used. Respondents were uncertain if UFH or LWMH are beneficial (67%, n=211), or harmful (61%, n=189) when used in this context, and 90%I(n=281) believe that further clinical trials or UFH or LMWH are warranted. Conclusion: Limited evidence to date suggests UFH may be beneficial when administered to patients with severe sepsis or septic shock. Future clinical trials are warranted and supported by a medical community that believes this avenue of research is clinically important and who is genuinely uncertain regarding the potential therapeutic benefits or harms of heparin in this patient population.
396

Molecular regulation of the Ste20-like kinase (SLK) by SRC-dependent pathways

Chaar, Ziad Y January 2005 (has links)
The Ste20-like kinase (SLK) is a conserved serine/threonine kinase that induces the dissociation of actin stress fibers in a Rac1-dependent manner. Recently, our laboratory has shown that SLK is a microtubule-associated protein regulating migratory components at the cell periphery in membrane ruffles and lamellipodia (Storbeck et al.; Wagner et al. unpublished data). To investigate the role of SLK during cell adhesion and migration, we used the Polyomavirus Enhancer Activator 3-null (PEA3(-/-/)) cell line, known to exhibit migration deficiencies. We observed that SLK redistribution to the cell periphery is altered in the PEA3(-/-) cells and that this phenotype could be rescued by the re-expression of PEA3 cDNA into PEA3(-/-) cells. Further analysis revealed that the PEA3(-/-) cells exhibit impaired c-src activation highlighted by decreased focal adhesion kinase (FAK) cleavage and reduced p130Cas tyrosine phosphorylation following fibronectin stimulation, suggesting that c-src activity and proper adhesion signaling may be required for SLK recruitment to the cell periphery. To further investigate FAK and c-src involvement in SLK redistribution to the cell periphery, we used FAK- or src, yes and fyn (SYF)-deficient cells. We have shown that SLK redistribution to the cell periphery is also altered in SYF deficient cells but not in FAK-deficient cells, suggesting that c-src mediates SLK redistribution to the cell periphery independently of FAK. SLK in vitro kinase assays performed on PEA3(-/-), FAK- and SYF-deficient cells revealed that SLK kinase activity is unaffected. However, v-src and c-srcY527F transformed cells displayed a 2- to 3-fold decrease in SLK kinase activity. Biochemical analysis revealed that SLK is hyperphosphorylated on serine residues in these cells with the kinase domain being the main target. Further analysis revealed that casein kinase II (CK2) phosphorylates the SLK kinase domain on serine 347/348 to downregulate SLK kinase activity. In addition, we also showed that CK2 kinase activity is dramatically increased in v-src-transformed cells and that the inhibition of CK2 restores SLK kinase activity. Overall, we showed that SLK redistribution to the cell periphery requires c-src, which can also regulate SLK kinase activity via CK2 to allow the turnover of adhesion sites and cytoskeletal rearrangements.
397

Studying fluid status and the dying: The challenge of clinical research in palliative care.

Viola, Raymond A. January 1997 (has links)
The investigation of the effects of fluid status and fluid therapy on the dying illustrates some of the obstacles to doing palliative care clinical research. Fluid status and fluid therapy. Objectives. Investigate the effects of fluid status and fluid therapy on the dying. Setting. Two inpatient palliative care units (PCUs), one in Ottawa (Ott) and one in Edmonton (Edm). 123 patients were approached for participation and 94 consented. These were followed in Phase I until 70 were at clinical risk of developing a fluid deficit and started the main phase of the study. (Phase II). Hypodermoclysis was given to all patients in Edm to maintain optimal fluid balance. No parenteral fluids were administered to Ott patients. Patients remained in Phase II until their risk of fluid deficit resolved for 10 days. The groups showed differences in indicators of fluid status, with poorer fluid status, the Ott group. The groups displayed differences at the start of Phase II in several symptom-related outcomes. Median survival in Ott from the start of Phase II was four days, and in Edm was 31.5 days. Both groups showed deterioration in cognitive status close to death. Myoclonus was more prevalent in Ott as were pressure ulcers, but there were no differences in level of consciousness or prevalence of edema. Drugs with sedating effects and with anticholinergic effects were used more often in Ott, while corticosteroids and oxygen were used more in Edm. Clinical research obstacles which are particularly relevant to palliative care and strategies for dealing with them were identified. Sixty-nine studies were identified. Eight included comparison groups and six of these were randomized trials. Obstacles were classified into four main categories: problems caused by the patients' poor and unstable conditions; ethical concerns; population heterogeneity; and lack of relevant outcome measures. (Abstract shortened by UMI.)
398

A pilot study of the bedside tests for aspiration in acute stroke.

Biem, Henry Jay. January 1998 (has links)
The aim of this thesis was to provide feasibility and statistical information that could be used to develop a grant proposal for a multidisciplinary study of the reliability and accuracy of the bedside diagnosis of aspiration and dysphagia in acute stroke patients. The objectives of this pilot study were: (1) To determine the feasibility of doing simple bedside tests for dysphagia and aspiration and determining intra-observer and inter-observer reliability. (2) To determine the required sample sizes to measure the inter-observer reliability of each of the video-recorded bedside tests with the Kappa statistic within a desired confidence interval based on estimates of the observed and expected agreements. (3) To determine the rate of admission of acute stroke patients at one hospital center and the approximate proportion of acute stroke patients who are eligible for enrollment and give consent. (4) To determine the approximate proportion of recruited acute stroke patients with the clinical outcomes of pneumonia and disruption of oral feeding. The pilot study used a prospective design to determine the agreement between two blinded observers for each of the various bedside tests recorded on videotape. It was conducted at Etobicoke General, a suburban community hospital. (Abstract shortened by UMI.)
399

EMS-witnessed cardiac arrest: Descriptive epidemiology, predictors of survival, and survival comparison with bystander-witnessed cardiac arrest.

De Maio, Valerie Jill. January 1998 (has links)
Statement of the problem. Cardiac arrest is the leading cause of death in Canada, yet it remains a problem with extremely poor prognosis. The prehospital response to cardiac arrest is critical since the majority of these events occur in the community, prior to the patient being transported to hospital. Cardiac arrests that occur after the arrival of trained emergency medical services (EMS) personnel (either ambulance or firefighters) may be a particularly homogeneous subgroup in which to assess not only mechanisms of cardiac arrest, but also the effectiveness of prehospital systems, and thereby contribute to our current understanding of the cardiac arrest condition. Objectives. The objectives of this study are threefold: (1) to elucidate the epidemiology of EMS-witnessed cardiac arrest in Ontario in terms of demographics, EMS-system and clinical characteristics, and rates of incidence and survival; (2) to determine predictors of survival to hospital discharge in this group; and (3) to compare outcomes among EMS-witnessed and bystander-witnessed cardiac arrest. (Abstract shortened by UMI.)
400

A pilot project to evaluate patient preferences in osteoporosis.

Cranney, Anne B. January 1998 (has links)
The study objective was to develop and evaluate the psychometric properties of preference-based measures in osteoporosis. Preference scenarios were constructed for marker health states associated with osteoporosis using the feeling thermometer. The reliability, validity and sensitivity to change of these measures and the standard gamble were evaluated in 42 women from four different patient subgroups. The four subgroups of women included women commencing hormone replacement, and women with recent wrist, vertebral or hip fractures. The reason for looking at different groups of women was to establish the feasibility of eliciting preferences in women with varying degrees of osteoporosis. Also, for cost-effectiveness analyses in osteoporosis, estimates of quality of life are required for the four different subgroups. The validity and sensitivity to change of the feeling thermometer and standard gamble were compared with the Health Utilities Index (HUI) and SF-36. All subgroups were reassessed 2-3 months following their first interview. (Abstract shortened by UMI.)

Page generated in 0.0845 seconds